The University of Chicago Header Logo

Connection

Mitchell C. Posner to Tegafur

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Tegafur.
Mitchell C. Posner
Connection Strength
0.011
Tegafur
  1. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Ann Oncol. 1998 Sep; 9(9):1035-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.